Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.

@article{Boyle2009LowTA,
  title={Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.},
  author={A. R. Boyle and Stuart D. Russell and Jeffrey J. Teuteberg and Mark S. Slaughter and Nader Moazami and Francis D. Pagani and O. Howard Frazier and Gerald Heatley and David Mascarenas Donald Hush James Theiler Charles Farrar and Ranjit John},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2009},
  volume={28 9},
  pages={881-7}
}
BACKGROUND The HeartMate II (Thoratec, Pleasanton, CA) is an effective bridge to transplantation (BTT) but requires anti-coagulation with warfarin and aspirin. We evaluated the risk of thromboembolism and hemorrhage related to the degree of anti-coagulation as reflected by the international normalized ratio (INR). METHODS INRs were measured monthly for 6 months in all discharged HeartMate II BTT patients and at an event. Each INR was assigned to ranges of INRs. Adverse events analyzed were… CONTINUE READING
111 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 111 extracted citations

Similar Papers

Loading similar papers…